Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments (2016 - 2025)

Ptc Therapeutics has reported Change in Acquisitions & Divestments over the past 13 years, most recently at $743.8 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $743.8 million for Q4 2025, up 406.45% from a year ago — trailing twelve months through Dec 2025 was $911.7 million (up 748.28% YoY), and the annual figure for FY2025 was $783.9 million, up 1528.81%.
  • Change in Acquisitions & Divestments for Q4 2025 was $743.8 million at Ptc Therapeutics, up from $23.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for PTCT hit a ceiling of $743.8 million in Q4 2025 and a floor of -$242.7 million in Q4 2024.
  • Median Change in Acquisitions & Divestments over the past 5 years was $21.1 million (2024), compared with a mean of $94.1 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 14300.0% in 2022 and later crashed 319.28% in 2024.
  • Ptc Therapeutics' Change in Acquisitions & Divestments stood at $450.7 million in 2021, then plummeted by 150.82% to -$229.0 million in 2022, then surged by 148.33% to $110.7 million in 2023, then crashed by 319.28% to -$242.7 million in 2024, then surged by 406.45% to $743.8 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $743.8 million (Q4 2025), $23.0 million (Q3 2025), and $8.2 million (Q2 2025) per Business Quant data.